Phosphatases are a superfamily of enzymes that hydrolyze the phosphate ester bond to remove phosphate groups from proteins, lipids, and nucleotides. As functional antagonists of protein kinases, they form the other half of the core cellular signaling regulatory network. Based on substrate specificity, phosphatases can be broadly categorized into:
Phosphatases fine-tune signaling thresholds in feedback loops and pathway crosstalk which enables them to control various pathological processes such as tumor immune evasion and metabolic diseases along with inflammation, fibrosis and neurodegeneration. PTP1B is a prototypical dual target in metabolic disease and oncology, SHP2 (PTPN11) has emerged as an oncotarget and master node of the RAS/MAPK pathway, and PTEN is the archetypal tumor suppressor. In all, phosphatases have recently emerged as a set of interesting drug targets, with drugs in various stages of development, including inhibitors, allosteric modulators, reversible and irreversible covalent inhibitors, and even targeted protein degraders (e.g., molecular glue or PROTAC approaches).
Creative Bioarray's Phosphatase Screening Services are designed to provide efficient and high-throughput in vitro activity assessment to accelerate your drug discovery programs. We offer comprehensive phosphatase activity assays and inhibitor screening to help you rapidly identify and optimize potential therapeutic candidates.
We utilize a fluorescence-based phosphatase activity assay employing the fluorogenic substrate DiFMUP (6,8-difluoro-4-methylumbelliferyl phosphate). While DiFMUP itself is non-fluorescent, enzymatic dephosphorylation releases DiFMU (6,8-difluoro-4-methylumbelliferone), a highly fluorescent product that emits at 460 nm upon excitation at 355 nm. By continuously monitoring changes in fluorescence intensity, we can accurately quantify phosphatase activity and evaluate compound-mediated inhibition.
Key advantages of this assay include:
Flexible service options
Advanced technology platform
Customized solutions
Our Phosphatase Screening Services provide high-quality, reproducible data to advance your drug discovery pipeline from hit identification through lead optimization. With broad target coverage, flexible service options, and deep scientific expertise, we are positioned to support your program at every stage of development.